Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension

B Zhou, P Perel, GA Mensah, M Ezzati - Nature Reviews Cardiology, 2021 - nature.com
High blood pressure is one of the most important risk factors for ischaemic heart disease,
stroke, other cardiovascular diseases, chronic kidney disease and dementia. Mean blood …

COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection

S Beyerstedt, EB Casaro, ÉB Rangel - European journal of clinical …, 2021 - Springer
COVID-19 pandemic is caused by the novel coronavirus SARS-CoV-2. Angiotensin-
converting enzyme 2 (ACE2) is not only an enzyme but also a functional receptor on cell …

2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with …

TM Maddox, JL Januzzi Jr, LA Allen, K Breathett… - Journal of the American …, 2021 - jacc.org
2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart
Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection …

COVID-19: breaking down a global health crisis

SI Mallah, OK Ghorab, S Al-Salmi, OS Abdellatif… - Annals of clinical …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is the second pandemic of the twenty-first
century, with over one-hundred million infections and over two million deaths to date. It is a …

COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives

M Nishiga, DW Wang, Y Han, DB Lewis… - Nature Reviews …, 2020 - nature.com
Abstract Coronavirus disease 2019 (COVID-19), caused by a strain of coronavirus known as
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global …

Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients …

RD Lopes, AVS Macedo, PGMBE Silva… - Jama, 2021 - jamanetwork.com
Importance It is unknown whether angiotensin-converting enzyme inhibitors (ACEIs) or
angiotensin II receptor blockers (ARBs) have a positive, neutral, or negative effect on clinical …

[HTML][HTML] Features, evaluation, and treatment of coronavirus (COVID-19)

M Cascella, M Rajnik, A Aleem, SC Dulebohn… - 2020 - europepmc.org
Objectives: Screen individuals based on exposure and symptom criteria to identify potential
COVID-19 cases. Identify the clinical features and radiological findings expected in patients …

Acute kidney injury in critically ill patients with COVID-19

P Gabarre, G Dumas, T Dupont, M Darmon… - Intensive care …, 2020 - Springer
Acute kidney injury (AKI) has been reported in up to 25% of critically-ill patients with SARS-
CoV-2 infection, especially in those with underlying comorbidities. AKI is associated with …

Covid-19 and COPD

JM Leung, M Niikura, CWT Yang… - European Respiratory …, 2020 - Eur Respiratory Soc
As of 11 July, 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
virus responsible for the coronavirus disease 2019 (COVID-19) pandemic has infected over …

Renin–angiotensin–aldosterone system inhibitors and risk of Covid-19

HR Reynolds, S Adhikari, C Pulgarin… - … England Journal of …, 2020 - Mass Medical Soc
Background There is concern about the potential of an increased risk related to medications
that act on the renin–angiotensin–aldosterone system in patients exposed to coronavirus …